{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:49:18Z","timestamp":1790174958485,"version":"4.1.0"},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"17","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple myeloma (MM) is a plasma cell malignancy of the bone marrow, which evolves from a premalignant stage called monoclonal gammopathy of undetermined significance (MGUS). In some patients, an intermediate stage referred to as smoldering multiple myeloma (SMM) is clinically recognized, with the full-bore malignancy termed MM. We conducted a study to assess differential CpG methylation at 1,500 genic loci during MM progression and profiled CD138+ plasma cells from MGUS, SMM, and MM specimens; human myeloma cell lines; and normal plasma cell (NPC) samples. We showed that the number of differentially methylated loci (DML) increased with tumor grade, and the vast majority were due to hypomethylation. Hierarchical clustering analysis revealed samples that coclustered tightly with NPC. These cases, referred to as \u201cnormal-like,\u201d contained significantly fewer DML when compared with their non\u2013normal-like counterparts and displayed overall methylation levels resembling NPC. This study represents one of the first methylome interrogation studies in MM and points toward global hypomethylation at genic CpG loci as an important and early mechanism driving myelomagenesis. Determining the set of critical genes and pathways based on the myeloma methylome is expected to lead to an improved understanding of biological mechanisms involved in myelomagenesis. Cancer Res; 70(17); 6934\u201344. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-0282","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T22:56:04Z","timestamp":1282690564000},"page":"6934-6944","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["DNA Methylation Analysis Determines the High Frequency of Genic Hypomethylation and Low Frequency of Hypermethylation Events in Plasma Cell Tumors"],"prefix":"10.1158","volume":"70","author":[{"given":"Bodour","family":"Salhia","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081The Translational Genomics Research Institute, Phoenix, Arizona; 2Mayo Clinic, Scottsdale, Arizona; and 3Multiple Myeloma Research Consortium, Norwalk, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Baker","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081The Translational Genomics Research Institute, Phoenix, Arizona; 2Mayo Clinic, Scottsdale, Arizona; and 3Multiple Myeloma Research Consortium, Norwalk, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Ahmann","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081The Translational Genomics Research Institute, Phoenix, Arizona; 2Mayo Clinic, Scottsdale, Arizona; and 3Multiple Myeloma Research Consortium, Norwalk, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Auclair","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081The Translational Genomics Research Institute, Phoenix, Arizona; 2Mayo Clinic, Scottsdale, Arizona; and 3Multiple Myeloma Research Consortium, Norwalk, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081The Translational Genomics Research Institute, Phoenix, Arizona; 2Mayo Clinic, Scottsdale, Arizona; and 3Multiple Myeloma Research Consortium, Norwalk, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Carpten","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081The Translational Genomics Research Institute, Phoenix, Arizona; 2Mayo Clinic, Scottsdale, Arizona; and 3Multiple Myeloma Research Consortium, Norwalk, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,8,31]]},"reference":[{"key":"2022061701374805200_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","article-title":"Genetic events in the pathogenesis of multiple myeloma","volume":"20","author":"Chng","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"2022061701374805200_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/asheducation-2001.1.157","article-title":"Multiple myeloma","author":"Dalton","year":"2001","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"2022061701374805200_bib3","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"Molecular classification of multiple myeloma: spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"2022061701374805200_bib4","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/carcin\/bgp149","article-title":"Differential repetitive DNA methylation in multiple myeloma molecular subgroups","volume":"30","author":"Bollati","year":"2009","journal-title":"Carcinogenesis"},{"key":"2022061701374805200_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/0008-5472.CAN-07-2531","article-title":"Genome-wide transcriptional response to 5-aza-2\u2032-deoxycytidine and trichostatin A in multiple myeloma cells","volume":"68","author":"Heller","year":"2008","journal-title":"Cancer Res"},{"key":"2022061701374805200_bib6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2141.2009.07976.x","article-title":"The potential role of epigenetic therapy in multiple myeloma","volume":"148","author":"Smith","year":"2010","journal-title":"Br J Haematol"},{"key":"2022061701374805200_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-\u03baB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"2022061701374805200_bib8","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1073\/pnas.93.24.13931","article-title":"Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma","volume":"93","author":"Bergsagel","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701374805200_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1101\/gr.4410706","article-title":"High-throughput DNA methylation profiling using universal bead arrays","volume":"16","author":"Bibikova","year":"2006","journal-title":"Genome Res"},{"key":"2022061701374805200_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mrfmmm.2004.07.022","article-title":"High-throughput SNP genotyping on universal bead arrays","volume":"573","author":"Shen","year":"2005","journal-title":"Mutat Res"},{"key":"2022061701374805200_bib11","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.4049\/jimmunol.178.9.5473","article-title":"Down-regulation of IL-7R\u03b1 expression in human T cells via DNA methylation","volume":"178","author":"Kim","year":"2007","journal-title":"J Immunol"},{"key":"2022061701374805200_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygeno.2009.12.001","article-title":"EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines","volume":"95","author":"Grafodatskaya","year":"2010","journal-title":"Genomics"},{"key":"2022061701374805200_bib13","first-page":"319","article-title":"Pathway mapping tools for analysis of high content data","volume":"356","author":"Ekins","year":"2007","journal-title":"Methods Mol Biol"},{"key":"2022061701374805200_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/bdrc.20163","article-title":"DNA methylation of cancer genome","volume":"87","author":"Cheung","year":"2009","journal-title":"Birth Defects Res Part C Embryo Today"},{"key":"2022061701374805200_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"2022061701374805200_bib16","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","article-title":"SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"2022061701374805200_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.leukres.2003.08.008","article-title":"Methylation profiling in multiple myeloma","volume":"28","author":"Chim","year":"2004","journal-title":"Leuk Res"},{"key":"2022061701374805200_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jcp.2006.038331","article-title":"Epigenetic dysregulation of the death-associated protein kinase\/p14\/HDM2\/p53\/Apaf-1 apoptosis pathway in multiple myeloma","volume":"60","author":"Chim","year":"2007","journal-title":"J Clin Pathol"},{"key":"2022061701374805200_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jcp.2006.036715","article-title":"Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"60","author":"Chim","year":"2007","journal-title":"J Clin Pathol"},{"key":"2022061701374805200_bib20","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/ijc.24431","article-title":"TGF\u03b2R2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma","volume":"125","author":"de Carvalho","year":"2009","journal-title":"Int J Cancer"},{"key":"2022061701374805200_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood-2006-09-049510","article-title":"Methylation and expression of the p16INK4A tumor suppressor gene in multiple myeloma","volume":"109","author":"Dib","year":"2007","journal-title":"Blood"},{"key":"2022061701374805200_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.leu.2401617","article-title":"De novo methylation of tumor suppressor gene p16\/INK4a is a frequent finding in multiple myeloma patients at diagnosis","volume":"14","author":"Gonzalez","year":"2000","journal-title":"Leukemia"},{"key":"2022061701374805200_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2009.02.002","article-title":"Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma","volume":"281","author":"Jost","year":"2009","journal-title":"Cancer Lett"},{"key":"2022061701374805200_bib24","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-08-3336","article-title":"Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma","volume":"15","author":"Nojima","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022061701374805200_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-009-0818-3","article-title":"DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance","volume":"89","author":"Stanganelli","year":"2010","journal-title":"Ann Hematol"},{"key":"2022061701374805200_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2141.1998.00724.x","article-title":"Methylation of the p16INK4A gene in multiple myeloma","volume":"101","author":"Tasaka","year":"1998","journal-title":"Br J Haematol"},{"key":"2022061701374805200_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1751-553X.2009.01146.x","article-title":"Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients","volume":"32","author":"Yuregir","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"2022061701374805200_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mgme.2001.3265","article-title":"Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential","volume":"75","author":"Fruhwald","year":"2002","journal-title":"Mol Genet Metab"},{"key":"2022061701374805200_bib29","first-page":"149","article-title":"Methylation matters: modeling a manageable genome","volume":"13","author":"Ordway","year":"2002","journal-title":"Cell Growth Differ"},{"key":"2022061701374805200_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.ejhg.5200768","article-title":"DNA methylation, imprinting and cancer","volume":"10","author":"Plass","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"2022061701374805200_bib31","first-page":"138","article-title":"DNA hypomethylation and human diseases","volume":"1775","author":"Wilson","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"2022061701374805200_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2009-07-232868","article-title":"Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia","volume":"115","author":"Kanduri","year":"2009","journal-title":"Blood"},{"key":"2022061701374805200_bib33","first-page":"101","article-title":"Methylation of p16 and p15 genes in multiple myeloma","volume":"17","author":"Chen","year":"2002","journal-title":"Chin Med Sci J"},{"key":"2022061701374805200_bib34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.leu.2404205","article-title":"Aberrant gene promoter methylation marking disease progression in multiple myeloma","volume":"20","author":"Chim","year":"2006","journal-title":"Leukemia"},{"key":"2022061701374805200_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/jcp.2005.031377","article-title":"High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma","volume":"59","author":"Song","year":"2006","journal-title":"J Clin Pathol"},{"key":"2022061701374805200_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/ijo_00000376","article-title":"Thalidomide alters nuclear architecture without ABCB1 gene modulation in drug-resistant myeloma cells","volume":"35","author":"Trussardi-Regnier","year":"2009","journal-title":"Int J Oncol"},{"key":"2022061701374805200_bib37","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 expression, function, and promoter methylation in human multiple myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"key":"2022061701374805200_bib38","first-page":"770","article-title":"Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group","volume":"6","author":"Dutcher","year":"1992","journal-title":"Leukemia"},{"key":"2022061701374805200_bib39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1345\/aph.1E612","article-title":"5-Azacytidine and decitabine monotherapies of myelodysplastic disorders","volume":"39","author":"Kuykendall","year":"2005","journal-title":"Ann Pharmacother"},{"key":"2022061701374805200_bib40","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2007-03-078576","article-title":"Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome","volume":"110","author":"Soriano","year":"2007","journal-title":"Blood"},{"key":"2022061701374805200_bib41","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2009-02-203547","article-title":"Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies","volume":"114","author":"Fandy","year":"2009","journal-title":"Blood"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/17\/6934\/2637400\/6934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/17\/6934\/2637400\/6934.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:29:42Z","timestamp":1655440182000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/17\/6934\/559602\/DNA-Methylation-Analysis-Determines-the-High"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,31]]},"references-count":41,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2010,8,31]]},"published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-0282","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22383125.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383131","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383128","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383128.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6500435","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6500435.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383131.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22383119.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383122.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383122","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383116.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383125","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383113","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383113.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383116","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383119","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,31]]}}}